DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BMS-986120
1
Unknown
Investigational
Unknown
Unknown
Thrombosis
Unknown
BMS-986120
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KPT-9274
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin
Unknown
KPT-9274
×
Maximum Phase:
1
First Approval:
None
UNII:
9T56TV18X7
Molecule Type:
Small molecule
Molecular Formula:
C35H29F3N4O3
Molecular Weight:
610.64
AlogP:
7.08
PSA:
101.46
HBD:
2.0
HBA:
#RotB:
7.0
Source:
VOROLANIB
1
Small molecule
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma
Unknown
VOROLANIB
×
Maximum Phase:
1
First Approval:
None
UNII:
YP8G3I74EL
Molecule Type:
Small molecule
Molecular Formula:
C23H26FN5O3
Molecular Weight:
439.49
AlogP:
2.75
PSA:
97.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AVID-200
1
Unknown
Investigational
Unknown
Unknown
Neoplasms; Scleroderma, Diffuse
Unknown
AVID-200
×
Maximum Phase:
1
First Approval:
None
UNII:
6EX05GL2VK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-3C5
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Vascular endothelial growth factor receptor 3 inhibitor
IMC-3C5
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ULILEDLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ULILEDLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DS-8273A
1
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms; Lymphoma; Melanoma
Unknown
DS-8273A
×
Maximum Phase:
1
First Approval:
None
UNII:
G674PEN33T
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MMI-0100
1
Protein
Investigational
Unknown
Unknown
Inflammation
Unknown
MMI-0100
×
Maximum Phase:
1
First Approval:
None
UNII:
6VP6PBL1ZH
Molecule Type:
Protein
Molecular Formula:
C98H171N37O26
Molecular Weight:
2283.68
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OLAPTESED PEGOL
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma; Pancreatic Neoplasms
Unknown
OLAPTESED PEGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
MTM792B442
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-6918
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
AZD-6918
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AQ-13
1
Unknown
Investigational
Unknown
Unknown
Malaria
Unknown
AQ-13
×
Maximum Phase:
1
First Approval:
None
UNII:
PKT9732S5K
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEMIRALISIB
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
PI3-kinase p110-delta subunit inhibitor
NEMIRALISIB
×
Maximum Phase:
1
First Approval:
None
UNII:
OEP8JJ3OZR
Molecule Type:
Small molecule
Molecular Formula:
C26H28N6O
Molecular Weight:
440.55
AlogP:
4.89
PSA:
76.98
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ELUBRIXIN TOSYLATE
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
ELUBRIXIN TOSYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
13FVR7WD4P
Molecule Type:
Small molecule
Molecular Formula:
C24H25Cl2FN4O7S2
Molecular Weight:
635.52
AlogP:
3.08
PSA:
110.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
TAFETINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAFETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
H4X2M2NN5N
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN4O2
Molecular Weight:
424.52
AlogP:
3.73
PSA:
77.23
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
AZD-4785
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
AZD-4785
×
Maximum Phase:
1
First Approval:
None
UNII:
D43WWD6RDZ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMGN-388
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Vitronectin receptor alpha binding agent
IMGN-388
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FAZ-053
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FAZ-053
×
Maximum Phase:
1
First Approval:
None
UNII:
V6W1OW12H2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
Y-39983
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Rho-associated protein kinase inhibitor
Y-39983
×
Maximum Phase:
1
First Approval:
None
UNII:
00ALI1GAY2
Molecule Type:
Small molecule
Molecular Formula:
C16H16N4O
Molecular Weight:
280.33
AlogP:
2.83
PSA:
83.8
HBD:
3.0
HBA:
#RotB:
3.0
Source:
IGN-523
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
IGN-523
×
Maximum Phase:
1
First Approval:
None
UNII:
7OI79TB6KN
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
N-HYDROXY-NOR-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
N-HYDROXY-NOR-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AGN-201904
1
Small molecule
Investigational
Unknown
Unknown
Peptic Ulcer
Unknown
AGN-201904
×
Maximum Phase:
1
First Approval:
None
UNII:
G0835O03ZM
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O8S2
Molecular Weight:
559.62
AlogP:
3.07
PSA:
146.91
HBD:
1.0
HBA:
#RotB:
10.0
Source:
LU AF82422
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LU AF82422
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BMS-984923
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
BMS-984923
×
Maximum Phase:
1
First Approval:
None
UNII:
3I1803DK5Z
Molecule Type:
Small molecule
Molecular Formula:
C22H15ClN2O2
Molecular Weight:
374.83
AlogP:
4.66
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
2.0
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ASP-4058
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP-4058
×
Maximum Phase:
1
First Approval:
None
UNII:
01J7526K2Q
Molecule Type:
Small molecule
Molecular Formula:
C19H12F6N4O2
Molecular Weight:
442.32
AlogP:
5.63
PSA:
76.83
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RG-7444
1
Antibody
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor 3 inhibitor
RG-7444
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SBC-103
1
Enzyme
Investigational
Unknown
Unknown
Unknown
Unknown
SBC-103
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MORAB-028
1
Antibody
Investigational
Unknown
Unknown
Melanoma
Disialoganglioside GD2 cross-linking agent
MORAB-028
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CENICRIVIROC MESYLATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CENICRIVIROC MESYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R96TV84T21
Molecule Type:
Small molecule
Molecular Formula:
C42H56N4O7S2
Molecular Weight:
793.06
AlogP:
8.74
PSA:
85.69
HBD:
1.0
HBA:
#RotB:
17.0
Source:
RG-7376
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase RAF inhibitor
RG-7376
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUSUIBU
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GUSUIBU
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
114
115
116
117
118
119
120
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA